logo
Elan Group-Led Renovation of SDM and Tehsil Offices in Gurugram Inaugurated by Deputy Commissioner, Gurugram Shri Ajay Kumar, IAS

Elan Group-Led Renovation of SDM and Tehsil Offices in Gurugram Inaugurated by Deputy Commissioner, Gurugram Shri Ajay Kumar, IAS

Business Upturn18 hours ago

About Elan Foundation
The Elan Foundation, the philanthropic arm of the Elan Group, was founded with the aim of improving the lives of the working class from marginalized backgrounds by addressing issues of poverty and enhancing access to basic necessities. Through continuous initiatives and endowments, the foundation endeavours to uplift the underprivileged, particularly blue-collar workers, and create a world where food and essential amenities are not causes for despair. With a focus on bridging gaps in rural infrastructure, promoting community development, environmental sustainability, and providing healthcare and rehabilitation support, The Elan Foundation is dedicated to fostering holistic socio-economic development.
About Elan Group
Elan Group was established with the aim to revolutionize the principles of 'Trust, Quality & Sustainability' in the real estate industry. Over the past decade, these foundation values have driven the company's remarkable growth, positioning Elan as a leader in the luxury real estate sector. The Group's unwavering commitment to delivering exceptional experiences and pioneering innovation has set new benchmarks in the industry. With a vision to 'Build the Future,' Elan Group is dedicated to transforming the Indian Realty landscape through its ultra-luxury projects across commercial, residential and hospitality sectors.
Through innovative designs, impeccable craftsmanship and a relentless focus on customer satisfaction, Elan group has redefined luxury living and commercial spaces. The company has consistently built a sterling reputation by exceeding expectations and delivering on its promises. These developments are designed to set new standards in luxury, sustainability and innovation with the goal of redefining urban living and commercial excellence.
Submit your press release
Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Life Science Labs Signal Shifting Strategies Amid New Economic Pressures, According to Survey of 550+ Researchers
Life Science Labs Signal Shifting Strategies Amid New Economic Pressures, According to Survey of 550+ Researchers

Yahoo

time35 minutes ago

  • Yahoo

Life Science Labs Signal Shifting Strategies Amid New Economic Pressures, According to Survey of 550+ Researchers

ARLINGTON, Va., June 13, 2025 /PRNewswire/ -- New survey insights reveal a measurable shift in how life science labs are responding to global financial uncertainty, rising operational costs, and upcoming U.S. tariff policies. Based on responses from more than 550 academic and industry researchers, the latest data from BioInformatics' Beyond the Bench series captures how lab priorities, purchasing decisions, and funding strategies have evolved from January to mid-April 2025—offering a rare pre- and post-policy view of market sentiment. While the first wave of the survey was fielded prior to the announcement of new tariff policies, the second wave offers a timely comparison as labs began adjusting to anticipated policy changes under the Trump administration and broader macroeconomic pressures, including inflation, tightened research budgets, and supply chain strain. Click here to download the Lab Budgets & Funding Survey Key Survey Findings Include: Funding confidence is declining, with only 57% of labs reporting confidence in securing 2025 funding—down from 66% in the first wave. Financial strain is hitting North American labs harder than those in Europe: 46% report new funding challenges (vs. 21% in Europe), and over half are considering personnel cuts, compared to just 28% in Europe. 42% of labs cite new concerns about securing funding through year-end, signaling heightened financial risk across the sector. Cost-saving strategies are accelerating, including resource sharing, supplier renegotiations, outsourcing, and delayed equipment purchases. These findings reflect shifting institutional priorities and underscore the growing need for timely, market-aligned planning as labs face increased constraints and financial pressure. "By fielding this survey before and after key policy announcements, we're able to offer a real-time snapshot of how labs are adjusting to economic volatility," said Richa Singh, VP, Market Insights at BioInformatics. "As tariff policies begin to reshape lab planning, companies need focused, evidence-backed insights to align their strategies. This data helps commercial teams track funding sentiment, adapt messaging, and make confident, evidence-based decisions—especially in a market where priorities can change within weeks." About Beyond the Bench Beyond the Bench is a free monthly intelligence series created by BioInformatics to help life science and diagnostics companies understand how customer sentiment and commercial priorities are shifting—particularly during times of uncertainty and industry disruption. Powered by the Science Advisory Board, BioInformatics' proprietary network of over 55,000 life science professionals, each report delivers survey-based insights on market trends, strategic shifts, and buyer behavior. The series was launched to provide a clear, unbiased view into the evolving challenges facing researchers and decision-makers—giving commercial teams actionable guidance to align strategy, messaging, and resource planning with what matters most to their customers. Access & Get Involved: Download the Lab Budgets & Funding Survey Sign up to receive monthly Beyond the Bench reports Join the Science Advisory Board — qualify to participate in surveys, earn rewards, and shape the future of scientific research. About BioInformatics BioInformatics, part of the Science and Medicine Group, is a leading market research and advisory firm serving the life science and diagnostic industries. The company delivers custom and syndicated research powered by a proprietary global panel of more than 55,000 professionals. View original content to download multimedia: SOURCE BioInformatics Inc.

Apple's $4.4B India Play: The Secret iPhone Shift That's Reshaping U.S. Supply Chains
Apple's $4.4B India Play: The Secret iPhone Shift That's Reshaping U.S. Supply Chains

Yahoo

time6 hours ago

  • Yahoo

Apple's $4.4B India Play: The Secret iPhone Shift That's Reshaping U.S. Supply Chains

Apple (NASDAQ:AAPL) is ramping up its India productionand fast. From January through May 2025, Foxconn (FXCOF) shipped $4.4 billion worth of India-assembled iPhones to the U.S., already beating 2024's full-year total of $3.7 billion. Between March and May, a staggering 97% of Foxconn's $3.2 billion exports went straight to the U.S., compared to just 50% last year. The push isn't subtle: Apple has been flying out iPhone 13, 14, 16, and 16e models on chartered planes and pressing Indian officials to cut customs clearance at Chennai airport from 30 hours down to six. Warning! GuruFocus has detected 6 Warning Sign with MSFT. This shift comes as Apple looks to de-risk from China ahead of what could be another round of sweeping tariffs. Donald Trump has floated a 55% duty on Chinese goods and slammed Apple's expansion into India, reportedly telling CEO Tim Cook, We are not interested in you building in India. India, meanwhile, is trying to dodge a separate 26% reciprocal tariff on top of its standard 10%. With the stakes this high, Apple's move to reroute its supply chain through India could be less about costand more about survival. It's also about time. Apple still sells 60 million iPhones a year in the U.S., with about 80% made in China. Tata Electronics, Apple's smaller Indian partner, is also stepping up. Nearly 86% of its March and April shipments went to the U.S., up from 52% across 2024. Analysts at Counterpoint Research believe India-made iPhones could hit 2530% of Apple's global shipments this yearup from just 18% in 2024. But India's still an expensive bet. High import duties on components make local assembly far from cheap. Still, Apple appears willing to absorb the extra costs in exchange for agility. The numbers suggest this isn't a trial run. It's a full pivot. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Apple's $4.4B India Play: The Secret iPhone Shift That's Reshaping U.S. Supply Chains
Apple's $4.4B India Play: The Secret iPhone Shift That's Reshaping U.S. Supply Chains

Yahoo

time6 hours ago

  • Yahoo

Apple's $4.4B India Play: The Secret iPhone Shift That's Reshaping U.S. Supply Chains

Apple (NASDAQ:AAPL) is ramping up its India productionand fast. From January through May 2025, Foxconn (FXCOF) shipped $4.4 billion worth of India-assembled iPhones to the U.S., already beating 2024's full-year total of $3.7 billion. Between March and May, a staggering 97% of Foxconn's $3.2 billion exports went straight to the U.S., compared to just 50% last year. The push isn't subtle: Apple has been flying out iPhone 13, 14, 16, and 16e models on chartered planes and pressing Indian officials to cut customs clearance at Chennai airport from 30 hours down to six. Warning! GuruFocus has detected 6 Warning Sign with MSFT. This shift comes as Apple looks to de-risk from China ahead of what could be another round of sweeping tariffs. Donald Trump has floated a 55% duty on Chinese goods and slammed Apple's expansion into India, reportedly telling CEO Tim Cook, We are not interested in you building in India. India, meanwhile, is trying to dodge a separate 26% reciprocal tariff on top of its standard 10%. With the stakes this high, Apple's move to reroute its supply chain through India could be less about costand more about survival. It's also about time. Apple still sells 60 million iPhones a year in the U.S., with about 80% made in China. Tata Electronics, Apple's smaller Indian partner, is also stepping up. Nearly 86% of its March and April shipments went to the U.S., up from 52% across 2024. Analysts at Counterpoint Research believe India-made iPhones could hit 2530% of Apple's global shipments this yearup from just 18% in 2024. But India's still an expensive bet. High import duties on components make local assembly far from cheap. Still, Apple appears willing to absorb the extra costs in exchange for agility. The numbers suggest this isn't a trial run. It's a full pivot. This article first appeared on GuruFocus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store